Holen Sie sich die Stockscreener-App
144.64
3.91%
-5.89
Handel nachbörslich:
144.64
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$150.53
Offen:
$151.13
24-Stunden-Volumen:
591.87K
Relative Volume:
0.84
Marktkapitalisierung:
$7.86B
Einnahmen:
$1.97B
Nettoeinkommen (Verlust:
$-494.50M
KGV:
-15.69
EPS:
-9.22
Netto-Cashflow:
$137.20M
1W Leistung:
-1.80%
1M Leistung:
-0.81%
6M Leistung:
-4.52%
1J Leistung:
+1.87%
1-Tages-Spanne:
$144.10
$151.16
1-Wochen-Bereich:
$144.10
$155.99
52-Wochen-Spanne:
$133.70
$194.88
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Vergleichen Sie MASI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
144.64 | 8.18B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Masimo Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Dec 3, 2025 Investor Day — Masimo presents growth strategy, innovation pipeline & long-term outlook - Stock Titan
Zero occult hypoxemia — Masimo INSPIRE feasibility study shows 1.47% ARMS accuracy in ICU patients - Stock Titan
Why Masimo (MASI) is a Top Growth Stock for the Long-Term - Yahoo Finance
Is the Options Market Predicting a Spike in Masimo Stock? - Yahoo Finance
Masimo (MASI): Assessing Valuation Amid Recent Performance Signals - simplywall.st
Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Conflict waiver shields Quinn Emanuel in Masimo shareholder suit - Daily Journal
With Sound United Gone, Masimo Files SEC Report Recasting Last 3 Years of Financials - Strata-gee.com
Apple Secures Victory In Masimo Patent Dispute With Token Damages Of $250 - MSN
3 Reasons MASI is Risky and 1 Stock to Buy Instead - The Globe and Mail
What analysts say about Masimo Corporation stockEnergy Sector Updates & Affordable Market Insights - earlytimes.in
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Barchart.com
Should You Add Inspirisys Solutions Limited Stock to Your Portfolio NowTechnical Pattern Recognition & Small Capital Growth Stocks - earlytimes.in
Masimo files pro forma financials after sale of consumer audio business to Harman - Investing.com
Masimo Corporation Securities Lawsuit Investigation - Claim Depot
Can you recover from losses in Masimo Corporation2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Will Masimo Corporation (3M4) stock deliver compounding returnsMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
How risky is Masimo Corporation stock nowEarnings Miss & Technical Entry and Exit Alerts - newser.com
Will Masimo Corporation (3M4) stock hit analyst forecasts2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com
Masimo Corporation (MASI): A Bull Case Theory - Yahoo Finance
Masimo (NASDAQ:MASI) Upgraded at Wall Street Zen - MarketBeat
How Masimo Corporation (3M4) stock benefits from digital adoptionTrade Exit Summary & Weekly High Potential Alerts - newser.com
Will Masimo Corporation (3M4) stock profit from AI boomOptions Play & Community Consensus Picks - newser.com
Samsung’s Harman Acquires Masimo Audio Brands for $350M Boost - WebProNews
Is Masimo Corporation (3M4) stock supported by free cash flowMarket Growth Report & Daily Volume Surge Signals - newser.com
Judge Plans To Let ITC Take Lead In Apple Watch Patent Fight - Law360
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI - Yahoo Finance
Apple Watch Imports at Risk if ITC Fails to Act, Judge Warns (1) - Bloomberg Law News
Masimo Completes Divestment of Consumer Audio Business to HARMAN - The Globe and Mail
Neonatal Infant Care Market Size Worth USD 6.70 Billion by 2034 Driven by Rising Preterm Birth Rates and Growing Demand for Advanced NICU Technologies - GlobeNewswire Inc.
Swedbank AB Trims Stock Position in Masimo Corporation $MASI - MarketBeat
Perpetual Ltd Sells 9,037 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Sells Sound United to HARMAN for $328M - The Globe and Mail
Masimo Completes Sale of Sound United to Harman International - Strata-gee.com
Harman completes acquisition of Sound United from Masimo By Investing.com - Investing.com South Africa
Masimo Completes $350M Sale of Consumer Audio Unit - Orange County Business Journal
Masimo completes sale of Sound United to HARMAN - Investing.com
Harman completes acquisition of Sound United from Masimo - Investing.com
Major Healthcare Tech Pivot: Masimo Sells Sound United to Samsung's HARMAN to Focus on Core Medical Business - Stock Titan
Harbor Capital Advisors Inc. Invests $4.44 Million in Masimo Corporation $MASI - MarketBeat
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):